推进现实世界的证据协调:英国,EMA和全球政策框架的经验教训
1Independent Consultant in Real-World Evidence & Health Data Science, London, UK.
Journal of comparative effectiveness research
|February 27, 2026
概括
现实世界证据 (RWE) 框架在全球范围内存在差异,导致效率低下. 协调RWE需要共同的标准和透明度,而不是更多的指导,以改善患者获得治疗的机会.
科学领域:
- 卫生政策 卫生政策
- 监管科学是一种监管科学.
- 卫生技术评估 卫生技术评估
背景情况:
- 从真实世界数据 (RWD) 获得的真实世界证据 (RWE) 对于监管和卫生技术评估 (HTA) 决策至关重要.
- 现有的RWE政策框架在不同司法管辖区之间是不一致的,原因是不同的应用 (安全,有效性,健康经济学).
- 这种碎片化可能导致患者获得新疗法的效率低下和延迟.
研究的目的:
- 为了比较十二个主要监管机构和HTA机构的RWE指导.
- 分析数据质量,统计方法,注册表治理和透明度的框架.
- 确定在RWE生成和评估中协调的机会.
主要方法:
- 对RWE指导文件进行叙述性比较性政策审查.
- 分析包括MHRA,EMA,FDA和CADTH在内的机构的框架.
- 在四个关键领域进行比较:数据质量,统计方法,治理和透明度.
主要成果:
- 对于RWE的高层原则显示趋同,但运营期望有很大的分歧.
- 像MHRA,EMA和FDA这样的机构有不同的方法 (灵活性与一致性与全面指导).
- 医疗技术评估机构增加了对比有效性和价值的标准,进一步分散了RWE的使用.
结论:
- 铁电的碎片化源于功能上的差异和运营上的错位.
- 协调需要共同的最低标准和透明度,而不仅仅是更多的指导方针.
- 合作试点,特别是利用英国脱欧后的立场,可以支持务实的调整.
关键词:
在HTA中,HTA就是HTA.这就是为什么RWD是RWD.在这里,RWE RWE RWE全球对齐全球对齐卫生技术评估 卫生技术评估政策协调与协调 政策协调与协调现实世界的数据数据.现实世界的证据.监管科学是一种监管科学.更多相关视频
08:27Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
7.3K
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
3.0K
相关概念视频
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...